BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27338259)

  • 21. Reversible pulmonary hypertension in POEMS syndrome--another etiology of triggered pulmonary vasculopathy?
    Paciocco G; Bossone E; Erba H; Rubenfire M
    Can J Cardiol; 2000 Aug; 16(8):1007-12. PubMed ID: 10978936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics, risk factors, and outcomes of POEMS syndrome: A longitudinal cohort study.
    Keddie S; Foldes D; Caimari F; Baldeweg SE; Bomsztyk J; Ziff OJ; Fehmi J; Cerner A; Jaunmuktane Z; Brandner S; Yong K; Manji H; Carr A; Rinaldi S; Reilly MM; D'Sa S; Lunn MP
    Neurology; 2020 Jul; 95(3):e268-e279. PubMed ID: 32606227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and risk factors of pleural effusions in patients with POEMS syndrome.
    Cui RT; Yu SY; Huang XS; Zhang JT; Tian CL; Dou LP; Pu CQ
    Hematol Oncol; 2015 Jun; 33(2):80-4. PubMed ID: 24519469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary hypertension in POEMS syndrome.
    Li J; Tian Z; Zheng HY; Zhang W; Duan MH; Liu YT; Cao XX; Zhou DB
    Haematologica; 2013 Mar; 98(3):393-8. PubMed ID: 22983590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [POEMS syndrome: role and value of interleukin-6].
    Andrès E; Courouau F; Kaltenbach G; Maloisel F; Imler M
    Rev Med Interne; 1996; 17(2):145-9. PubMed ID: 8787086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ocular features of polyneuropathy-organomegaly-endocrinopathy-monoclonal gammopathy-skin changes syndrome].
    Dai RP; Dong FT; Chu J
    Zhonghua Yan Ke Za Zhi; 2005 Oct; 41(10):917-9. PubMed ID: 16271178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment.
    Kourelis TV; Buadi FK; Gertz MA; Lacy MQ; Kumar SK; Kapoor P; Go RS; Lust JA; Hayman SR; Rajkumar V; Zeldenrust SR; Russell SJ; Dingli D; Lin Y; Leung N; Hwa YL; Gonsalves W; Kyle RA; Dispenzieri A
    Leukemia; 2016 May; 30(5):1079-85. PubMed ID: 26669974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombocytosis distinguishes POEMS syndrome from chronic inflammatory demyelinating polyneuropathy.
    Naddaf E; Dispenzieri A; Mandrekar J; Mauermann ML
    Muscle Nerve; 2015 Oct; 52(4):658-9. PubMed ID: 26179010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum immunoglobulin free light chain and heavy/light chain measurements in POEMS syndrome.
    Wang C; Su W; Zhang W; Di Q; Duan MH; Ji W; Cao XX; Zhou DB; Li J
    Ann Hematol; 2014 Jul; 93(7):1201-6. PubMed ID: 24482101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [POEMS syndrome. A report of four cases].
    Andresik D; Russo MP
    Medicina (B Aires); 2015; 75(5):324-7. PubMed ID: 26502470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyneuropathy improvement following autologous stem cell transplantation for POEMS syndrome.
    Karam C; Klein CJ; Dispenzieri A; Dyck PJ; Mandrekar J; D'Souza A; Mauermann ML
    Neurology; 2015 May; 84(19):1981-7. PubMed ID: 25878176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Important prognostic factors for survival in patients with malignant pleural effusion.
    Zamboni MM; da Silva CT; Baretta R; Cunha ET; Cardoso GP
    BMC Pulm Med; 2015 Mar; 15():29. PubMed ID: 25887349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Papilloedema and POEMS syndrome].
    Munteanu GH; Munteanu M; Budău M
    Oftalmologia; 2001; 53(3):35-44. PubMed ID: 11915688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. POEMS syndrome: importance of the clinical laboratory practitioner's role.
    Levinson SS
    Clin Chim Acta; 2012 Nov; 413(21-22):1800-7. PubMed ID: 22771968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous manifestations in patients with POEMS syndrome.
    Miest RY; Comfere NI; Dispenzieri A; Lohse CM; el-Azhary RA
    Int J Dermatol; 2013 Nov; 52(11):1349-56. PubMed ID: 23557151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical observation of thalidomide combined with VAD regimen for treatment of osteosclerotic myeloma (POEMS syndrome)].
    Zhou JW; Sun H; Gan SL; Liu YF; Sun L; Wan DM; Meng XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):348-51. PubMed ID: 22541096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) treated with autologous hematopoietic stem cell transplantation: a case report and literature review.
    Arana C; Pérez de León JA; Gómez-Moreno G; Pérez-Cano R; Martín Hernández T
    Am J Case Rep; 2015 Mar; 16():124-9. PubMed ID: 25726020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case report: POEMS syndrome in childhood.
    Sevketoglu E; Hatipoglu S; Ayan I; Dogan O; Salihoglu B
    J Pediatr Hematol Oncol; 2008 Mar; 30(3):235-8. PubMed ID: 18376288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skin sclerosis as a manifestation of POEMS syndrome.
    Hasegawa M; Orito H; Yamamoto K; Matsushita T; Hamaguchi Y; Fujimoto M; Takehara K
    J Dermatol; 2012 Nov; 39(11):922-6. PubMed ID: 22724593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. POEMS syndrome: failure of newly suggested diagnostic criteria to anticipate the development of the syndrome.
    Ofran Y; Elinav E
    Am J Hematol; 2005 Aug; 79(4):316-8. PubMed ID: 16044435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.